07.04.2015 Views

Two examples of bio-guided isolation, synthesis and ...

Two examples of bio-guided isolation, synthesis and ...

Two examples of bio-guided isolation, synthesis and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Two</strong> Examples <strong>of</strong><br />

Bio<strong>guided</strong> Isolation, Synthesis <strong>and</strong> Pharmacomodulation <strong>of</strong><br />

Natural Products from Annonaceae <strong>and</strong> Rutaceae<br />

Dr Bruno FIGADERE<br />

Laboratories <strong>of</strong> Natural Substances Chemistry<br />

(Pharmacognosy), UMR 8076-BioCIS<br />

Faculty <strong>of</strong> Pharmacy, University Paris-Sud<br />

Thai-Franco Seminar on Natural Substances<br />

27 September 2005<br />

BioCIS (UMR CNRS 8076)


Laboratory <strong>of</strong> Chemistry <strong>of</strong> Natural Substances<br />

- Extraction <strong>of</strong> natural products with <strong>bio</strong>logical properties<br />

- Natural products <strong>and</strong> analogues: <strong>synthesis</strong> <strong>and</strong> semi-<strong>synthesis</strong><br />

- Total Synthesis <strong>of</strong> Natural Products<br />

- Antiparasitic Chemiotherapy<br />

BioCIS (UMR CNRS 8076)


Bio<strong>guided</strong> Extraction - Leishmanicidal Compounds:<br />

The Chimanines, 1st Example<br />

- in Bolivia, Galipea longiflora (Rutaceae) is traditionally used<br />

against cutaneous leishmaniasis<br />

- <strong>bio</strong><strong>guided</strong> fractionation <strong>and</strong> purification led to <strong>bio</strong>logical active<br />

alcaloides<br />

N<br />

N<br />

OMe<br />

O<br />

N<br />

N<br />

N<br />

N<br />

O<br />

O<br />

(Fournet, A.et al J. Nat. Prod. 1993, 56, 1547-1552)<br />

BioCIS (UMR CNRS 8076)


Synthesis <strong>of</strong> 2-substituted quinolines (part 1)<br />

H 2 O 2<br />

ClCOOiBu, t he n RMgBr<br />

N<br />

N<br />

O<br />

35-90 %<br />

(Fakhfakh,M.A.. et al Tetrahedron Lett. 2001, 42, 3847)<br />

N<br />

R<br />

N<br />

(67%)<br />

N<br />

(79%)<br />

N<br />

(73%)<br />

N<br />

(53%)<br />

N<br />

(82%)<br />

N<br />

(68%)<br />

N<br />

(63%)<br />

N<br />

(35%)<br />

N<br />

(75%)<br />

SiMe 3<br />

N<br />

(66%)<br />

BioCIS (UMR CNRS 8076)


Synthesis <strong>of</strong> 2-substituted quinolines (part 2)<br />

Wittig<br />

N R N<br />

O<br />

Br<br />

N<br />

(89%)<br />

Br<br />

N<br />

(80%)<br />

CO 2 Et<br />

N<br />

CHO<br />

N<br />

OMe<br />

(64%)<br />

(80%)<br />

N C 5 H 11<br />

N CO 2 Et<br />

(84%) (63%)<br />

BioCIS (UMR CNRS 8076)<br />

N CN N NO 2<br />

(80%) (70%)<br />

(Fakhfakh,M.A. et al Synth. Commun. 2002, 32, 2863)


Synthesis <strong>of</strong> 2- or 3-substituted quinolines (part 3)<br />

N<br />

Cl<br />

RMgX, Fe(acac) 3<br />

THF, -10 °C-0 °C<br />

N<br />

R<br />

N<br />

76%<br />

N<br />

36%<br />

OH<br />

75% N<br />

N<br />

75%<br />

N<br />

70%<br />

(Seck M. et al Tet. Lett. 2004, 45, 1881-1884)<br />

BioCIS (UMR CNRS 8076)


Synthesis <strong>of</strong> 2- substituted quinolines (part 4)<br />

N<br />

OH<br />

Z<br />

F<br />

NO 2<br />

N(CH 3 ) 2<br />

OCH 3<br />

N<br />

H<br />

N<br />

Z<br />

N<br />

O<br />

N<br />

NCH 3<br />

N<br />

OH<br />

CO 2 Me<br />

N<br />

O<br />

Bu<br />

N<br />

O<br />

OEt<br />

N<br />

OH<br />

OMe<br />

OMe<br />

R<br />

N<br />

R<br />

H<br />

Ph<br />

CO 2 Me<br />

N<br />

Z<br />

F<br />

NO 2<br />

N(CH 3 ) 2<br />

OCH 3<br />

N<br />

R<br />

N<br />

N<br />

O<br />

O<br />

n<br />

O<br />

n=1or 7<br />

O<br />

N<br />

N<br />

N<br />

N<br />

O<br />

O<br />

N<br />

N<br />

N<br />

N<br />

BioCIS (UMR CNRS 8076)


In vitro activity <strong>of</strong> synthetic quinolines (IC 50 µM)<br />

L. am az onensis<br />

L. infant um L. donovani<br />

cytotoxicity (macrophages<br />

N<br />

5<br />

32 -<br />

41<br />

N<br />

CHO<br />

4<br />

2 -<br />

9<br />

N<br />

OH<br />

4<br />

2 -<br />

34<br />

N<br />

Br<br />

3<br />

2 -<br />

13<br />

21<br />

32 1,2<br />

40<br />

N<br />

N<br />

CO 2 Me<br />

59<br />

26 3,3<br />

>200<br />

N<br />

37<br />

12 -<br />

74<br />

amphotericine B 0,12<br />

Gluca nt im e 20<br />

pentamidine -<br />

BioCIS (UMR CNRS 8076)<br />

- -<br />

7 -<br />

- 1<br />

-<br />

-<br />

-


In vivo activity <strong>of</strong> synthetic quinolines<br />

L. infantum Balb/c infected mice (10 days treatment by oral administration 2x12.5<br />

mg/kg/d)<br />

Gluca nt im e<br />

% <strong>of</strong> reduction <strong>of</strong> parasites<br />

in the liver<br />

- 65,3<br />

% <strong>of</strong> reduction <strong>of</strong> parasites<br />

in t he s ple e n<br />

+ 6,0%<br />

N<br />

- 1 3,3<br />

+ 95,6<br />

N SiMe 3<br />

- 3 7,8<br />

- 23,8<br />

N<br />

- 60,0<br />

- 47,6<br />

N<br />

OMe<br />

- 6 0,0<br />

- 64,3<br />

N<br />

CHO<br />

- 91,6<br />

- 47,6<br />

N<br />

CH 2 OH<br />

- 51,1<br />

- 3 8,1<br />

N Br<br />

BioCIS (UMR CNRS 8076)<br />

- 24,4 - 33,3<br />

(Fakhfakh, M.A. e t al PCT/FR02/00140 ; PCT Int. Appl. WO 02 57,238 ; CA 2002, 137, 125093m)


Bio<strong>guided</strong> Extraction - Cytotoxic Compounds:<br />

The Acetogenins <strong>of</strong> Annonaceae, 2nd Example<br />

O OH OH<br />

O<br />

1<br />

n<br />

O<br />

S<br />

O<br />

O<br />

O<br />

O<br />

O<br />

O<br />

type A1<br />

O<br />

OH<br />

BioCIS (UMR CNRS 8076)<br />

goniocin (type D1)<br />

OH<br />

reticulatamol (type E)<br />

R, R, R, R : threo-trans-threo<br />

S,R,S,R : threo-cis-threo<br />

n=1, m=3, threo-trans-threo : trans-solamin<br />

n=1, m=3, threo-cis-threo : cis-solamin<br />

n=3, m=3, threo-trans-threo : reticulatacin<br />

n=3, m=3, threo-trans-erythro : reticulatain 1<br />

n=5, m=1, threo-trans-erythro : reticulatain 2<br />

n=5, m=1, threo-trans-threo : uvariamicin 3<br />

OH<br />

OH<br />

O O<br />

O<br />

isomolvizarin (type B2)<br />

OH<br />

O O<br />

Figadère, Cortes et al. Nat. Prod. Rep. 2005, 22, 269-303<br />

m


Acetogenins <strong>of</strong> Annonaceae<br />

O<br />

O<br />

O<br />

OH<br />

O O OH<br />

O<br />

O<br />

O<br />

rolliniastatin 2<br />

OH<br />

O<br />

OH<br />

iso-rolliniastatin 2<br />

antitumoral activity on grafted mice<br />

OH<br />

Products<br />

rolliniastatin 2<br />

iso-rolliniastatin 2<br />

paclitaxel<br />

BioCIS (UMR CNRS 8076)<br />

Quantity(/day)<br />

µg/kg<br />

200<br />

100<br />

50<br />

25<br />

12<br />

800<br />

400<br />

200<br />

100<br />

50<br />

25<br />

25000<br />

17500<br />

15000<br />

7000<br />

4400<br />

% T/C Variation <strong>of</strong> weight<br />

TOX<br />

106<br />

138<br />

125<br />

113<br />

144<br />

144<br />

125<br />

113<br />

113<br />

100<br />

90<br />

105<br />

139<br />

114<br />

117<br />

(g/mouse)<br />

-2,9<br />

-2,6<br />

-0,4<br />

0,6<br />

0,9<br />

0,5<br />

1,1<br />

1,8<br />

1,6<br />

2,1<br />

1,7<br />

-4,4<br />

-2,4<br />

-2,5<br />

-1,1<br />

-0,9


Semi<strong>synthesis</strong>- Perspectives <strong>and</strong> collaborations<br />

Acetogenins <strong>of</strong>’Annonaceae: collaboration with Pasteur Institute, ICSN (Gif-s-Yvette, France)<br />

fluorescent probe (visualisation)<br />

Proteomic<br />

N 3<br />

OR<br />

O<br />

O<br />

OR<br />

O<br />

O<br />

protection, azide formation<br />

OH<br />

OH<br />

O<br />

O<br />

OH<br />

O<br />

O<br />

squamocine<br />

OH<br />

OH<br />

O<br />

KMnO 4<br />

O<br />

OH<br />

OH<br />

R<br />

radical decarboxylation +<br />

O<br />

R<br />

O<br />

R R<br />

OH OH<br />

OH O O<br />

O O<br />

R<br />

BioCIS (UMR CNRS 8076)<br />

R<br />

O<br />

R


Biomimetic Total Synthesis <strong>of</strong> Solamin (part 1)<br />

Z<br />

E<br />

O<br />

O<br />

pseudo- muricadienin<br />

AD-mix β<br />

HO<br />

O<br />

O<br />

OH<br />

oxidation<br />

O<br />

O<br />

O<br />

O<br />

BioCIS (UMR CNRS 8076)<br />

OH<br />

15 R<br />

16 R<br />

O<br />

trans-solamin<br />

or<br />

OH<br />

20 R<br />

19 R<br />

OH OH<br />

15 S<br />

O 20 R<br />

16 S 19 R<br />

cis-solamin<br />

or<br />

diastereomers


Biomimetic Total Synthesis <strong>of</strong> Solamin (part 2)<br />

MeO<br />

O<br />

Z<br />

E<br />

MeO<br />

O<br />

4 steps<br />

Z<br />

Br<br />

+<br />

Metal<br />

E<br />

2 steps<br />

O<br />

O<br />

OH<br />

OH<br />

Figadère, Tetrahedron Lett. 1999, 40, 4041 <strong>and</strong> Let t . Org. Chem . 2004, 1 ,<br />

316-322.<br />

O<br />

BioCIS (UMR CNRS 8076)


Conclusion<br />

- From several plants,<strong>bio</strong>-<strong>guided</strong> <strong>isolation</strong> led to natural 2-substituted quinolines that have shown<br />

promising in vivo activity against a murine model <strong>of</strong> visceral leishmaniasis; <strong>bio</strong><strong>guided</strong> <strong>synthesis</strong><br />

then allowed us to obtain suitable products for preclinical trials<br />

- From several Annonaceae, <strong>bio</strong>-<strong>guided</strong> <strong>isolation</strong> has afforded a series <strong>of</strong> new cytotoxic compounds<br />

the acetogenins <strong>of</strong> Annonaceae; semi-<strong>synthesis</strong>, <strong>and</strong> total <strong>synthesis</strong> gave so far, some information<br />

on the structure-activity relationship, as well as on the cellular target.<br />

BioCIS (UMR CNRS 8076)


BioCIS (UMR CNRS 8076)


BioCIS (UMR CNRS 8076)


BioCIS (UMR CNRS 8076)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!